Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop
about
Structure and function of a potent agonist for the semi-invariant natural killer T cell receptorStructure of Antibody F425-B4e8 in Complex with a V3 Peptide Reveals a New Binding Mode for HIV-1 NeutralizationStructure determination of an anti-HIV-1 Fab 447-52D–peptide complex from an epitaxially twinned data setCrystal Structure of the HIV-2 Neutralizing Fab Fragment 7C8 with High Specificity to the V3 Region of gp125Rabbit Anti-HIV-1 Monoclonal Antibodies Raised by Immunization Can Mimic the Antigen-Binding Modes of Antibodies Derived from HIV-1-Infected HumansStructure of a V3-containing HIV-1 gp120 coreDetermining the invariant structure elements of the HIV-1 variable V3 loops: insight into the HIV-MN and HIV-Haiti isolates.Dual spatial folds and different local structures of the HIV-1 immunogenic crown in various virus isolates.Conformational preferences of the HIV-1 principal neutralizing determinant.Structural analysis of the HIV-1 gp120 V3 loop: application to the HIV-Haiti isolates.Development of peptide mimics of a protective epitope of Vibrio cholerae Ogawa O-antigen and investigation of the structural basis of peptide mimicry.An optimally constrained V3 peptide is a better immunogen than its linear homolog or HIV-1 gp120Structural basis of clade-specific HIV-1 neutralization by humanized anti-V3 monoclonal antibody KD-247.Molecular mechanisms of FIV infection.Production, purification, crystallization and preliminary X-ray diffraction analysis of the HIV-2-neutralizing V3 loop-specific Fab fragment 7C8.Human immunodeficiency virus-1 gp120 V3 loop for anti-acquired immune deficiency syndrome drug discovery: computer-aided approaches to the problem solving.Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodiesAntibody-Mediated Catalysis in Infection and Immunity.Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis.Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer.Crystal structures of human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity.Mimicking the structure of the V3 epitope bound to HIV-1 neutralizing antibodiesFold recognition of the human immunodeficiency virus type 1 V3 loop and flexibility of its crown structure during the course of adaptation to a host.Computational model of the HIV-1 subtype A V3 loop: study on the conformational mobility for structure-based anti-AIDS drug design.Synthetic virus-like particles and conformationally constrained peptidomimetics in vaccine design.Computational anti-AIDS drug design based on the analysis of the specific interactions between immunophilins and the HIV-1 gp120 V3 loop. Application to the FK506-binding protein.Structural analysis of the envelope gp120 V3 loop for some HIV-1 variants circulating in the countries of Eastern Europe.
P2860
Q24672186-0EF56D77-8C46-4C39-8129-7D4D3F9717B3Q27649247-15B08F01-2D75-4004-8605-0E8482D1A1DBQ27650903-0471F973-213C-46D7-B3C3-813E30C040FEQ27667679-44039728-6CD4-4762-8D22-B0CBCD78C3B4Q27679123-B4A62999-E3EC-4CE2-A398-47F2B5A7CC64Q29619014-F2B7E88E-5C0A-4283-9E5D-805D42508178Q30370415-BEA565A7-85F6-4707-8C9B-6F3EC9E697ADQ30952700-1DEBCC16-07EF-4BF4-AEDC-B2758F1EE977Q31010762-24F2DED9-88F7-4AD6-AEDB-A7BD3E973A58Q31112947-A832CDA2-CE3A-4EBA-B54E-2A3743133F0FQ33299645-CEC01E73-36D7-4D35-A1EE-AF0635024D53Q33820645-B2AC7179-C4D1-4D27-A5D0-952543F60353Q34847834-E904A0CF-F55A-4748-9AF0-6522F9F97FE9Q36692802-C4E6B104-30C4-40B5-9190-598FCDBFBD48Q37250087-5121B383-5D1B-43B3-A9C9-9E40DE7A6159Q38014473-0EE037C5-3548-4AC9-9DBC-7FF35ABC7C64Q38739398-FEA6A79A-9110-4C45-A729-9E34A1AD79D8Q39412526-E1582C1C-F201-4745-AA96-66AD9612A6CFQ40147993-B473D81E-4CCD-4FBC-816A-AE155AA1BD58Q40957217-7378CA5C-6248-4B17-B395-AE009324D86FQ42031529-53E42E42-C49B-4471-B875-4AA65ACBA4F4Q42576275-8C0A0558-753A-4FA2-AFB1-E93C9547B2E7Q42712576-D8319843-9448-4015-8B27-D391962001A3Q44111505-ED7230A6-6CD4-4B53-86EE-AB280972B69DQ45361823-91BE8361-965C-4474-AC49-9C7CC996AE0BQ46148250-4C70C6E1-CAE8-4037-8C84-867D33DF82AAQ47269444-4279231B-BBE5-48B4-9504-080799EA4AF8
P2860
Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop
@ast
Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop
@en
Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop
@nl
type
label
Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop
@ast
Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop
@en
Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop
@nl
prefLabel
Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop
@ast
Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop
@en
Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop
@nl
P2093
P1433
P1476
Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop
@en
P2093
Albert T Profy
Jayant B Ghiara
Robyn L Stanfield
P304
P356
10.1016/S0042-6822(03)00525-7
P407
P577
2003-10-10T00:00:00Z